MarketPeel
Insider Trading Intelligence
Pricing
…
JC

Jon Congleton

MLYS
CHIEF EXECUTIVE OFFICER · MINERALYS THERAPEUTICS, INC. · CIK 0001644975
FILING MIX · LIFETIME30%/70%
BUYS
12
SELLS
28
TOTAL VALUE
$17.25M
COMPANIES
2
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
682,061
AVG SELL PX
$28.57
TRADE KIND
SHOWING 40 / 40
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 41 pending
Forward-return performance of every backtestable P/S trade by Jon Congleton, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+55.17%-0.53%-0.41%-0.12%-0.66%—
14d29+65.52%-3.07%+1.15%-4.22%-5.93%—
30d29+51.72%-1.62%+2.87%-4.49%-9.24%—
60d29+68.97%-3.04%+1.38%-6.66%-17.11%—
90d29(1 pending)+75.00%-2.51%+3.82%-6.33%-14.97%—
180d29(6 pending)+60.87%+10.54%+10.03%+0.52%-9.68%—
1y29(15 pending)+7.14%+51.58%+17.67%+33.91%+3.77%—
2y29(19 pending)+40.00%+138.64%+41.16%+97.47%+55.70%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MLYS · 631,321 shares · as of Jun 30, 2026
0262,267524,534786,8011,049,068202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 28 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
58,000$25.94$1.50M631,321Jun 30, 2026Jun 30, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,000$26.82$455.9K614,321Jun 30, 2026Jun 30, 2026 ↗View →
IMUX
IMMUNIC, INC.
PURCHASEGRANT
Stock grant
50,740——50,740Jun 29, 2026Jun 29, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,730$26.83$422.0K689,321Apr 13, 2026Apr 15, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,364$25.50$493.8K760,687Mar 31, 2026Apr 2, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
55,183$26.54$1.46M705,504Mar 31, 2026Apr 2, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
453$27.05$12.3K705,051Mar 31, 2026Apr 2, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
187,900——187,900Feb 19, 2026Feb 20, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,900——780,051Feb 19, 2026Feb 20, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,117$33.15$235.9K639,151Jan 12, 2026Jan 13, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,119$32.21$293.7K646,268Jan 12, 2026Jan 13, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
24,082$0.54$13.0K655,387Nov 21, 2025Nov 24, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
24,082——0Nov 21, 2025Nov 24, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
12,806$41.64$533.2K818,499Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
8,862$42.31$374.9K809,637Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
32,850$46.89$1.54M631,305Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
4,000$43.50$174.0K805,637Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
112,275$45.83$5.15M664,155Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
Chief Executive Officer
29,207$45.20$1.32M776,430Nov 11, 2025Nov 13, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,552$43.03$66.8K831,305Oct 13, 2025Oct 15, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,548$42.63$577.5K832,857Oct 13, 2025Oct 15, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,884$14.51$230.4K846,405Jul 11, 2025Jul 15, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,319$12.19$186.8K862,289Apr 11, 2025Apr 15, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
570,000——570,000Feb 13, 2025Feb 24, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,333$9.06$166.1K877,608Jan 13, 2025Jan 15, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,271$13.52$206.4K895,941Oct 11, 2024Oct 15, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,746$13.34$210.1K911,212Jul 11, 2024Jul 12, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,940$11.73$175.2K926,958Jun 20, 2024Jun 20, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,607$11.99$199.1K941,898Jun 18, 2024Jun 20, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,766$12.25$217.7K958,505Jun 17, 2024Jun 20, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,229$12.52$203.2K976,271Jun 14, 2024Jun 14, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
39,961$12.74$509.0K992,500Jun 13, 2024Jun 14, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,607$12.77$212.0K1,032,461Jun 12, 2024Jun 14, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
425,000——425,000Feb 13, 2024Feb 15, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
4,250$5.97$25.4K1,049,068Nov 22, 2023Nov 27, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,250$12.08$27.2K1,044,818Sep 6, 2023Sep 8, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,250$12.10$27.2K1,042,568Aug 17, 2023Aug 21, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,000$12.89$25.8K1,040,318Aug 11, 2023Aug 11, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
99,800——99,800Mar 17, 2023Mar 21, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,046——250,046Feb 9, 2023Feb 13, 2023 ↗View →
Other insiders · MLYS
Loading peer insiders…
About this filer
CIK 0001644975
ROLE
Chief Executive Officer
PRIMARY
MLYS
COMPANIES
2
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001644975DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback